Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	176.56	-55.30	20.00
Graham Fair Price	41.56	0.10	0.07
PEG	-38.47	0.41	-0.67
Price/Book	9.72	0.57	0.52
Price/Cash Flow	-68.06	5.58	17.46
Prices/Earnings	-45.14	35.31	64.36
Price/Sales	56.51	37.76	24.12
Price/FCF	-68.06	5.58	17.46
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-15.99	-0.84	1.00
Operating Margin	-59.25	-1.45	-0.91
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	0.02	-0.04	99.90
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	-1.28	-0.12	90.92
EPS QOQ	-0.96	0.86	-10.84
FCF QOQ	1.28	2.44	90.11
Revenue QOQ	-0.87	-0.30	65.64
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	3696.69	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	0.26	100.00
Quick Ratio	0.66	0.78	18.19
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.34	0.34	0.10
Cash	0.02	0.04	110.99
Capex	< 0.005	< 0.005	-100.46
Free Cash Flow	< 0.005	0.03	243.85
Revenue	< 0.005	< 0.005	-29.83
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.66	1.52	129.60
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.60	-19.04	-632.84
Naive Interpretation	Member

06 - Financial Health · Weak

Rating